The long non-coding RNA GUARDIN functions to protect genome stability. Inhibiting GUARDIN expression can alter cell fate decisions towards senescence or apoptosis, but the underlying molecular signals are unknown. Here we show that GUARDIN is an essential component of a transcriptional repressor complex involving LRP130 and PGC1ɑ which suppresses FOXO4 expression. GUARDIN acts as a scaffold to stabilize LRP130/PGC1ɑ heterodimers and their occupancy at the FOXO4 promotor. Destabilizing this complex by silencing of GUARDIN, LRP130 or PGC1ɑ leads to FOXO4dependent upregulation of p21, thereby driving cells into senescence. We also found that GUARDIN expression was induced by rapamycin, a senolytic agent that suppresses cell senescence. FOS-Like Antigen 2 (FOSL2) acts as a transcriptional repressor of GUARDIN with increased levels in the presence of rapamycin resulting from downregulation of FOSL2. Together, these results demonstrate that GUARDIN inhibits p21-dependent senescence through a LRP130-PGC1ɑ-FOXO4 signaling axis and moreover, GUARDIN contributes to the anti-senolytic activities of rapamycin.
Introduction
Senescence is an irreversible state of cellular dormancy driven by various mechanisms such as replicative exhaustion resulting from telomere shortening or uncapping, oncogene activation, and genotoxic, nutrient and oxidative stress (1) . These mechanisms commonly cumulate in the DNA damage response (DDR) leading to activation of the tumor suppressor p53 and the expression of cyclin-dependent kinase (CDK) inhibitors such as p21 and p16 that execute the senescent response.
Although cellular senescence was initially regarded as a passive cell-autonomous anti-proliferation program echoing normal cellular aging (2, 3) , it is increasingly appreciated that senescence plays an important role in many other physiological and pathological processes including tumor suppression, neurodegeneration and tissue remodeling (4, 5) . Moreover, the senescence-associated secretory phenotype (SASP) resulting from changes in the secretome of senescent cells contributes to regulating inflammation, tissue microenvironment and age-related disorders (6) (7) (8) .
As an important regulatory mechanism of cellular senescence that integrates a variety of extracellular and intracellular signals (1) , the mechanistic target of rapamycin (mTOR; as known as mammalian target of rapamycin) plays an important role in regulating longevity (6) . Inhibition of mTOR signaling by genetic or pharmacological approaches extends lifespan of various model organisms and mice with different genetic backgrounds (7) (8) (9) (10) . Indeed, treatment with the mTOR inhibitor rapamycin or its analogs (rapalogs) reduces cellular senescence (11) (12) (13) (14) . Nevertheless, the molecular mechanisms involved in rapamycin-mediated inhibition of senescence are not well understood.
An increasing number of noncoding RNAs have been found to be involved in regulation of cellular senescence (15) . For example, the long noncoding RNA MIR31HG regulates the expression of p16 to modulate oncogene-induced senescence (16) , whereas HOTAIR activates cellular senescence through p53-p21 signaling of the DDR (17) . Moreover, the lncRNA OVAAL blocks cellular senescence through regulating the expression of the CDK inhibitor p27 (18) . We have also found that the lncRNA GUARDIN plays an essential role in maintaining genomic stability (19) . Silencing of GUARDIN was shown to induce cellular senescence although the mechanism responsible remains undefined.
In this report, we demonstrate that GUARDIN serves to facilitate assembly of the complex between 
Results

GUARDIN inhibits cellular senescence through suppressing transcriptional activation of p21
To validate the notion that GUARDIN protects cells from cellular senescence (19) , we knocked down GUARDIN using shRNA in normal human adult foreskin fibroblasts (HAFF), non-small cell lung carcinoma cells (A549 and H1299), and hepatocellular carcinoma HepG2 cells, respectively ( Figure   EV 1A) . We observed that shRNA silencing of GUARDIN induced senescence-associatedgalactosidase (SA-gal) activity ( Figure 1A) , the formation of senescence associated heterochromatin foci (SAHF) as shown by increased levels of H3K9me3 ( Figure 1B) , and enhanced the senescenceassociated secretory phenotype (SASP) as represented by elevated extracellular levels of IL-6 and IL-8 in A549 cells ( Figure 1C ) (20) . Knockdown efficiencies varied from 50-90%, possibly due to the varied endogenous expression profiles of GUARDIN observed among the different cell lines ( Figure   EV 1A, B ). Alternatively, overexpression of GUARDIN accelerated cell proliferation ( Figure EV 1D , E) consistent with prior reports (19) . Northern blotting analysis of GUARDIN in H1299 and A549 cells showed a single band of 985nt ( Figure EV 1C) , consistent with the three exon transcript reported previously (19) . Thus, loss of GUARDIN induces senescence while its overexpression promotes proliferation in cell lines from different sources.
The induction of senescence following GUARDIN silencing was associated with upregulation of p21 protein, a factor which is well known to be involved in triggering senescence (21) . In contrast, the expression of other senescence-inducing proteins, such as p15 and p16 (22) , remained unaltered ( Figure 1D ). Indeed, p21 expression appeared critical for the induction of senescence caused by GUARDIN silencing, as co-silencing of p21 abolished SA--gal activity induced by GUARDIN knockdown ( Figure 1E , Figure EV 1F ). Together, these results suggest that GUARDIN silencing induces senescence through upregulation of p21. Indeed, we observed increased p21 mRNA levels in cells following knockdown of GUARDIN, and consistent with this notion, overexpression of GUARDIN caused a decrease in p21 transcription levels ( Figure 1F ). Of note, GUARDIN knockdown or overexpression did not affect the expression of p53 ( Figure 1G ), nor did it impact on p53 transcription activity, since knockdown of GUARDIN failed to influence the expression of other p53 transcription targets including Noxa, TIGAR and Bax ( Figure 1H ) (23) . Moreover, GUARDIN knockdown also caused upregulation of p21 and activation of senescence in p53-null H1299 cells ( Figure 1F , G). These data indicated that p53 is not involved in GUARDIN-mediated upregulation of p21.
To understand how silencing of GUARDIN could influence p21 expression, we first measured the effect of GUARDIN knockdown on the turnover of the p21 protein. Instructively there were no changes in the half-life time of p21 (Figure EV 1G) upon GUARDIN depletion, indicating that GUARDIN did not influence the post-translational stability of p21. Furthermore, treatment with the general transcription inhibitor actinomycin D (Act D) did not lead to noticeable changes in the turnover rate of p21 mRNA (Figure EV 1H) (24) , suggesting that p21 upregulation was not a consequence of an increased p21 mRNA stability, rather, it occurred through upregulated transcription. Thus, GUARDIN appears to inhibit cellular senescence through repressing transcriptional activation of p21.
GUARDIN facilitates LRP130/PGC1ɑ interaction that mediates the transcriptional repression of p21
To investigate the mechanism responsible for GUARDIN-mediated suppression of p21, we interrogated the protein interactome of GUARDIN using RNA pulldown assays, and proteins that coprecipitated with biotin-labelled antisense probe against GUARDIN were identified by mass spectrometry (Figure 2A ). Binding between GUARDIN and LRP130 was subsequently confirmed by Western blotting ( Figure 2B ). Consistently, the interaction of LRP130 and GUARDIN was readily detected using RNA immunoprecipitation (RIP) assay and RNA FISH ( Figure 2C , D). Moreover, subcellular fractionation assays showed that GUARDIN and LRP130 were localized to both nuclear and the cytoplasmic compartments ( Figure EV 2A, B ), together indicating that LRP130 is a bona fide binding partner of GUARDIN.
LRP130 is a transcription factor shown previously to functionally complex with PGC1ɑ to exert effects on gene expression (25) . RNA pulldown assays performed with GUARDIN also showed the presence of PGC1α ( Figure 2E ) suggesting that GUARDIN may associate with the LRP130-PGC1ɑ complex.
Consistently, RNA immunoprecipitation (RIP) assay showed association between GUARDIN and PGC1α ( Figure 2F ). To verify that GUARDIN associates with the LRP130-PGC1ɑ complex, we introduced FLAG-tagged LRP130 into A549 cells and conducted two-step IP assays from total protein extracts. In the first phase IP, FLAG antibodies precipitated LRP130 along with PGC1ɑ and GUARDIN while in the second phase IP, PGC1ɑ antibodies co-precipitated LRP130 and GUARDIN ( Figure 2G ), indicating GUARDIN, LRP130 and PGC1ɑ exist as a ternary complex. Instructively, GUARDIN knockdown diminished the relative amount of LRP130 associated with PGC1ɑ as shown in co-immunoprecipitation (Co-IP) and mammalian two-hybrid assays ( Figure 2H , I), indicating that GUARDIN functions to facilitate interactions between LRP130 and PGC1ɑ.
We also investigated the structural basis of the interaction of GUARDIN with LRP130 and PGC1ɑ by We next examined whether LRP130 and PGC1ɑ play roles in GUARDIN-mediated repression of p21.
ShRNA knockdown of either LRP130 or PGC1 resulted in upregulation of p21 at both mRNA and protein levels ( Figure 2J ), recapitulating the effects of GUARDIN depletion on p21 ( Figure 2K ). Thus, the association of LRP130 and PGC1ɑ facilitated by GUARDIN appears necessary for GUARDINmediated repression of p21 expression.
GUARDIN/LRP130/PGC1ɑ represses transcription of FOXO4 gene
To investigate whether LRP130/PGC1ɑ was involved directly in transcriptional regulation of p21, we interrogated the p21 promoter region for the presence of LRP13/PGC1 the UCSC browser predicted LRP130/PGC1ɑ binding sites were found embedded within DNase I hypersensitive regions (DHSs) within the p21 gene promoter (-1870/-1701, -1430/-1221, -395/-1 upstream of the transcription start site) ( Figure 3A , lower part). DHSs mark diverse classes of cisregulatory regions, such as promoters and enhancers and their identification represents a powerful method of identifying the location of gene regulatory elements, including promoters (26) (27) (28) .
Nevertheless, neither LRP130 nor PGC1ɑ were found to directly bind to p21 promoter using ChIP assays whereas TP53, a bona fide p21 transcriptional driver, was shown to bind to the p1(-1870/-1701) and p4 (-395/-200) binding sites ( Figure 3A , upper part). These results implied that the upregulation of p21 by LRP13/PGC1ɑ was unlikely to be mediated through direct transcription.
To clarify the mechanism by which GUARDIN suppresses p21 expression and cellular senescence, we Verification using qPCR showed that FOXO4, but not FOXO1 and FOXO3a mRNA levels were increased upon GUARDIN knockdown ( Figure 3B ). Importantly, knockdown of FOXO4 not only reduced p21 expression but also diminished the increase in p21 caused by GUARDIN knockdown ( Figure 3C ). Collectively, these results suggest that GUARDIN-mediated repression of p21 may be due to suppression of FOXO4. Silencing of GUARDIN had no effect on the turnover rate of FOXO4 mRNA when treated with ActD ( Figure 3D ), suggesting that regulation of FOXO4 by GUARDIN was unlikely to affect FOXO4 mRNA stability. In support of this notion, we identified multiple consensus 
GUARDIN is transcribed by FOSL2 that is responsive to rapamycin
The senolytic agent rapamycin inhibits senescence through a number of different mechanisms including but not only, inhibition of mTOR (11, 12) . We investigated whether GUARDIN contributes to or even cooperates with rapamycin to inhibit senescence. Indeed, rapamycin treatment resulted in upregulation of GUARDIN, both in a time-and dose-dependent manner ( Figure 4A, B) . Intriguingly, the downregulation of p21 by rapamycin treatment was mediated through GUARDIN, since the p21dependent cellular senescence caused by GUARDIN depletion was reversed by rapamycin treatment ( Figure 4C , D). Rapamycin treatment increased the relative amount of LRP130 associated with PGC1ɑ as shown in mammalian two-hybrid assays ( Figure 4E ), recapitulating the effects of GUARDIN.
Therefore, GUARDIN is not only a rapamycin-responsive lncRNA, but also it contributes to the rapamycin-mediated inhibition of senescence. Moreover, the levels of p53 did not change upon rapamycin treatment ( Figure 4C ), implying that rapamycin does not regulate GUARDIN through p53.
To explore the mechanism responsible for the rapamycin-induced upregulation of GUARDIN, we interrogated microarray gene expression data derived from tumor tissues with or without rapamycin treatment (GSE39694; Gene Expression Omnibus (GEO)). Among the 629 genes altered by treatment with rapamycin there were 38 encoding transcription factors ( Figure EV 4A, Dataset EV3 ) .
Inspecting the genomic sequence in the GUARDIN promoter using the JASPAR database (30) identified putative binding sites for SIX Homeobox 4 (SIX4), FOS-Like Antigen 2 (FOSL2) and ATAbinding protein (TBP) ( Figure EV 4B ). Further assessment of the levels of these transcription factors showed that SIX4 and FOSL2 were downregulated at mRNA and protein levels, whereas TBP remained unchanged in response to rapamycin treatment ( Figure 4F ). Moreover, knockdown of FOSL2 but not SIX4 caused upregulation of GUARDIN and downregulation of p21 ( Figure 4G ), suggesting that FOSL2 expression underpinned the rapamycin-dependent changes in GUARDIN expression.
Consistently, overexpression of FOSL2 caused downregulation of GUARDIN and upregulation of p21
( Figure 4G ), recapitulating the effects of rapamycin treatment on GUARDIN and p21 expression ( Figure 4A , B, C). Additionally, FOSL2 knockdown increased the transcriptional activity of the -784/-54 GUARDIN reporter construct whereas reporter levels after SIX4 shRNA were unchanged from controls ( Figure 4H ). In addition, ChIP assays demonstrated that FOSL2 bound to its predicted binding sites (-503 to -493) in the GUARDIN promoter ( Figure 4I ). Together these results indicate that binding of FOSL2 to the GUARDIN promoter transcriptionally represses its expression. Thus, rapamycin suppresses FOSL2 and subsequently upregulates GUARDIN leading to suppression of p21 and inhibition of cellular senescence.
Discussion
We have previously shown that GUARDIN is a p53-responsive lncRNA and is essential for cell survival and proliferation through maintaining genomic integrity in response to DNA damage (19) . In this report, we provide evidence that GUARDIN is also responsive to rapamycin to suppress cellular senescence through facilitating LRP130/PGC1ɑ-mediated repression of FOXO4 leading to transcriptional inactivation of p21. Moreover, we show that repression of FOSL2 is responsible for upregulation of GUARDIN in response to rapamycin. These results not only reveal a p53-independent mechanism that regulates GUARDIN expression, but also uncover a novel signaling pathway of cellular senescence induced by rapamycin.
While replicative exhaustion resulting from telomere shortening or uncapping is a common driver of cellular senescence (21), an important mechanism through which GUARDIN protects genomic integrity is to maintain the expression of telomeric repeat binding factor 2 (TRF2), a component of the shelterin complex critical for capping telomeres (31) . Indeed, we found that senescence induced by GUARDIN knockdown was mediated by p21, as knockdown of GUARDIN upregulated p21 and coknockdown of p21 diminished senescence resulting from GUARDIN knockdown, consistent with the role of GUARDIN in protecting genomic integrity (19) . Intriguingly, GUARDIN-mediated regulation of p21 expression appeared to be independent of p53, although p21 is a major effector of p53 signaling and we have previously shown that GUARDIN, similar to p21, may represent an indicator of wild-type p53 activity (19) . Nevertheless, p53-independent regulation of p21 has been widely documented and GUARDIN was also detectable in TP53-null cells and tumors with mutations in TP53 (19) . Our results further consolidate that notion that both GUARDIN and p21 can function independently of p53 and point to a GUARDIN-mediated mechanism that transcriptionally represses p21 irrespective of p53 activation status.
Previously we have found that GUARDIN acts as an RNA scaffold to facilitate the binding between BRCA1 and BARD in response to DNA damage (19 PGC1ɑ is a transcriptional cofactor that interacts with multiple transcription factors (32) while LRP130
is a leucine-rich repeat-containing protein (also known as LRPPRC) functionally associated with mitophagy induction (33) but also with demonstrated transcriptional and/or translational roles in the nucleus and endoplasmic reticulum (34) . The LRP130/PGC1ɑ complex plays a critical role in glucose homeostasis and energy balance through regulation of gluconeogenic and mitochondrial genes (25, 35) .
Interestingly, previous studies show that PGC1ɑ is a binding partner and coactivator of FOXO1 which drives the expression of gluconeogenic genes in liver (25, 36) while in contrast, PGC1α acts at the FOXO3 promoter to suppress its expression in skeletal muscle (37) . Finally, we establish that GUARDIN expression is induced in cells in response to the mTOR inhibitor, rapamycin. This agent has long been known to inhibit cellular senescence and prolong life span in various model systems (13, 40) . However, the mechanisms involved remain less understood and are thought to be multifactorial. We found that GUARDIN contributes to rapamycin-mediated inhibition of cellular senescence, opening a novel scenario that rapamycin protects against cellular aging through a noncoding mechanism. Instructively, treatment with rapamycin did not activate p53, consistent with senescence representing a p53-independent aspect of GUARDIN function. The upregulation of GUARDIN by rapamycin was mediated through downregulation of FOSL2. FOSL2 was shown to exert transcriptional repression of GUARDIN through occupancy of the GUARDIN promoter although how rapamycin effects downregulation of FOSL2 is not currently known.
In summary, we have identified a signaling axis encompassing GUARDIN, LRP130/ PGC1ɑ, FOXO4
and p21 that can suppress cellular senescence ( Figure 5 ). Manipulating GUARDIN levels by inhibition or overexpression acted to either trigger or block senescence. An important question involves how the contextual placement of GUARDIN's functions involving genomic maintenance versus its role in senescence. The latter involves negative control of gene expression that conceivably may act as a failsafe switch under conditions where GUARDIN expression is compromised although this thesis remains to be explored. Nevertheless, as GUARDIN is responsive to treatment with rapamycin, our findings also highlight a potential role for GUARDIN in aging-associated diseases with perhaps practical implications in aging-prevention.
Materials and Methods
Reagents and antibodies
Reagents and antibodies were sourced as indicated: cycloheximide (Sigma); rapamycin (BBI); actinomycin D (Solarbio); streptavidin beads (Invitrogen); A/G beads (Pierce); anti-H3K9me3, p15, 
Cell culture
HepG2, A549, H1299, 293T and HAFF cells were cultured in DMEM (Invitrogen) supplemented with 10% FBS / 1% penicillin/streptomycin and maintained in a humidified incubator at 37 °C/ 5% CO2. All cells were authenticated by STR profiling (GenePrint 10 System kit from Promega and AuthentiFiler PCR Amplification Kit from ThermoFisher) and tested negative for mycoplasma contamination using the Cell Culture Contamination Detection Kit (ThermoFisher).
RNA interference and gene overexpression
Lentiviruses for gene knockdown and overexpression experiments, respectively, were generated by transfecting HEK293T cells for 48 h with PLKO.1 based shRNAs, pREV, pGag and pVSVG (2:2:2:1 ratio) or psin/pCDH, pspax2, pmd2.g (2:2:1 ratio). Supernatants were 0.45 um filtered, supplemented with 8 µg/ml polybrene (Sigma) before incubating with target cells and selecting with 1 mg/ml puromycin. Targeting sequences are shown in Appendix Table S1 .
Quantitative and semi-quantitative RT-PCR
Total RNA was isolated by TRIzol reagent (Invitrogen) and 500 ng RNA used to synthesize cDNA using PrimeScriptTM RT reagent kit (TaKaRa) according to the manufacturer's instructions. Semiquantitative RT-PCR was performed using 2x Taq PCR mix with 25 cycles for internal controls and 30-40 cycles for RNAs. Primer sequences are shown in Appendix Table S1 . QPCR was performed as described previously (41).
β-Galactosidase staining and quantitation
β-galactosidase staining was performed according to the manufacturers protocol (C0602, Beyotime). βgalactosidase-positive cells were scored using light microscopy from three random fields.
Immunofluorescence and RNA FISH
Cells grown on coverslips were fixed in 4% paraformaldehyde and permeabilized using 0.2% Triton X-100. After blocking with 2% BSA, coverslips were incubated overnight at 4 °C with primary antibodies before addition of Alexa-488 secondary antibodies. RNA probes synthesized by T7-mediated transcription were purified by phenol-chloroform extraction and 1 mg RNA labelled with Alexa-546 protein A/G beads alone before IP with the indicated antibodies at 4°C for 3 hr. After washing, the bead-bound immunocomplexes were eluted using elution buffer (50 mM Tris, pH 8.0, 1% SDS, and 10 mM EDTA) at 65°C for 10 min. To isolate protein-associated RNAs from the eluted immunocomplexes, samples were treated with proteinase K, and RNAs were extracted by phenol/chloroform before RT-PCR analysis.
In vitro transcription
The T7 RNA polymerase promoter sequence was introduced into DNA templates generated by PCR to allow for in vitro transcription. PCR products were purified using the DNA Gel Extraction Kit Appendix Table S1 .
ChIP assay
Cells were crosslinked with 1% formaldehyde for 10 min and ChIP assays performed using the Pierce Agarose ChIP kit (ThermoScientific, USA) according to the manufacturer's instructions. Anti-rabbit immunoglobulin G was used as a negative control. Bound DNA fragments were subjected to RT-PCR using the specific primers (Appendix Table S1 ).
Luciferase reporter assay
Luciferase reporter assays were performed as described previously (43) using the Dual-Luciferase
Reporter Assay System (Promega, Madison, WI, USA).
Subcellular fractionation
Cells were incubated with hypotonic buffer (25 mM Tris-HCl, pH 7.4, 1 mM MgCl 2 , 2.5 mM KCl) on ice for 5 min. An equal volume of hypotonic buffer containing 1% NP-40 was then added, and each sample was left on ice for another 5 min. After centrifugation at 5000 g for 5 min, the supernatant was collected as the cytosolic fraction. The pellets were re-suspended in nuclear resuspension buffer (20 mM HEPES, pH 7.9, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF), and incubated at 4°C for 30 min. Nuclear fractions were collected after removing insoluble membrane debris by centrifugation at 12,000 g for 10 min.
RNA-seq
Total RNA was extracted by phenol/chloroform and RNA-seq analysis performed by Shanghai Biotechnology.
Mammalian Two-Hybrid assays
Complementary DNAs for PGC1α and LRP130 cloned into the pBIND and pACT vectors were transfected along with pG5luc vector (Promega) and reporter activity measured 48 h later using the Dual-Luciferase Reporter Assay Kit (Promega). Renila measurements were used to normalize changes in firefly luciferase activity.
Quantification and Statistical analysis
Statistical analysis was carried out using Microsoft Excel 2016 and GraphPad Prism 7 to assess differences between experimental groups. Densitometry was performed using Image-Pro plus 6.0 software. Statistical significance was analyzed by two-tailed Student's t-test for comparisons of two samples, one-way ANOVA with Tukey's post-test for univariate comparisons, two-way ANOVA with
Bonferroni's post-test for bivariate comparisons. P values lower than 0.05 were considered to be statistically significant. (ns, not significant, * P< 0.05, ** P< 0.01, *** P < 0.001).
Data Availability
Raw and normalized data files for the microarray analysis have been deposited in the NCBI Gene Figure EV2 . 
